Figure 2.
Kaplan‐Meier estimates for time to discontinuation from lacosamide monotherapy in subgroups of patients who (A) received lacosamide as first‐line lacosamide and (B) converted to lacosamide monotherapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.